4//SEC Filing
Theravance Biopharma, Inc. 4
Accession 0001179110-15-012299
$TBPHCIK 0001583107operating
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 8:26 PM ET
Size
4.9 KB
Accession
0001179110-15-012299
Insider Transaction Report
Form 4
MALKIEL BURTON G
Director
Transactions
- Purchase
Ordinary Shares
2015-08-18$12.92/sh+10,000$129,200→ 20,571 total
Footnotes (1)
- [F1]Represents the weighted average purchase price per share for the open market purchase on August 18, 2015. The shares were purchased at prices ranging from $12.75 to $12.99 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001583107
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 8:26 PM ET
- Size
- 4.9 KB